Orbenin Extra Dry Cow

£57.46 - £404.06 (exc VAT)

£68.95 - £484.87 (inc VAT)

An off-white stable suspension of cloxacillin as the benzathine salt in a long-acting mineral oil base, prepared under sterile conditions. It is presented in syringes containing 600 mg cloxacillin as the benzathine salt, in 3.6 g of suspension.

Orbenin Extra Dry Cow is recommended for routine use in cows at drying off, to treat existing intramammary infections and to provide prolonged protection against new infections during the dry period. The concomitant use of Orbeseal™ at drying off provides additional protection against the ingress of udder pathogens, contributing to preventing both subclinical infections and clinical mastitis during early lactation.

Orbenin is active against Gram-positive organisms associated with mastitis. These include: Streptococcus agalactiae, Streptococcus dysgalactiae, Streptococcus uberis, penicillin-resistant and sensitive staphylococci, and Actinomyces pyogenes. Orbenin is bactericidal in action and is not destroyed by staphylococcal beta-lactamase. It is, therefore, active against penicillin-resistant staphylococci which are an important cause of mastitis.

Orbenin Extra Dry Cow formulation is non-irritant to udder tissues and maintains effective antibiotic levels in the majority of quarters for at least 7 weeks after infusion. It thus provides an extended period of protection against new infection.

Legal Category: POM-V


One syringe per quarter immediately after the final milking of a lactation.

At drying off clean and disinfect the teat end thoroughly with surgical spirit following the last milking. Insert nozzle into teat and apply gentle and continuous pressure until suspension is expressed. After infusion it is advisable to dip each teat in a licensed teat dip.

Each syringe may only be used once. Part used syringes must be disposed of.

Withdrawal Period

The following applies to the use of Orbenin Extra Dry Cow either alone or in combination with Orbeseal. Not intended for use in cows with dry periods of 42 days or less. Milk for human consumption may only be taken from 96 hours after calving. If calving occurs before 42 days after the last treatment, milk for human consumption may only be taken from 42 days plus 96 hours after the last treatment.

Animals must not be slaughtered for human consumption during treatment. Cattle may be slaughtered for human consumption only after 28 days from the last treatment.

Contra Indications

Do not use in the lactating cow. If lactating cows are accidentally infused, milk should be withheld from the bulk supply for 46 days or less time if testing shows cloxacillin residues below the MRL of 0.03 mcg/ml.

Size: 24, 120

NOAH Datasheet

For the most up to date information about this product please look up the Summary of Product Characteristics (SPC) on the VMD webpage Product Information Database.

24 Price: £57.46 (exc VAT)

POM-V Declaration

120 Price: £404.06 (exc VAT)

POM-V Declaration


Related Products